Search

everythinglearnresearchcommunity

for

Search:↓

Thyroid disease can cause skin, hair, and nail problems, and treating the thyroid condition often improves these symptoms.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Runx1 controls fat-related genes important for normal and cancer cell growth, affecting skin and hair cell behavior.

Skin stem cells are crucial for maintaining and repairing skin, with potential for treating skin disorders and improving wound healing.

Early recognition and management of skin side effects from new cancer therapies can prevent treatment delays.

Advancements in nanoformulations for CRISPR-Cas9 genome editing can respond to specific triggers for controlled gene editing, showing promise in treating incurable diseases, but challenges like precision and system design complexity still need to be addressed.

Different types of skin cells have unique genetic markers that affect how likely they are to spread cancer.

Dabrafenib can cause skin growths and sometimes low-grade skin cancer.

Reflectance confocal microscopy reliably identifies skin cancer features like horizontal skin tissue sections.

Scalp basal cell carcinoma may be more aggressive and harder to treat than other types, requiring special attention and further research.

Targeted therapy for skin cancer is complex due to the role of the hedgehog pathway in both cancer and hair growth.

PKC ε increases hair follicle stem cell turnover and may raise skin cancer risk.

Vismodegib is effective for basal cell carcinoma but has severe side effects.

GLI1 might protect against the start of skin cancer and is not linked to cancer severity.

A rare type of skin cancer on the scalp can be mistaken for hair loss, causing delayed diagnosis and severe damage.

Understanding and managing side effects of hedgehog pathway inhibitors can improve treatment for advanced basal cell carcinoma.

Activating Notch signaling can kill basal cell carcinoma cells.

LGR5 and LGR6 are expressed differently in various skin tumors, which may offer clues about their origins.

The combination therapy is effective and well-tolerated for treating esophageal cancer.

New melanoma treatments can cause skin side effects, including skin cancer and rashes, but combining treatments may reduce these risks.

The conclusion is that Pigmented Epithelioid Melanocytoma can start from hair follicle stem cells or from a mole on the skin.

The document concludes that identifying the specific cells where skin cancers begin is important for creating better prevention, detection, and treatment methods.

Contact immunotherapy might help treat various skin conditions, but more research is needed to confirm its safety and effectiveness.

Organ transplant recipients have a higher risk of skin cancer over time, atopic dermatitis skin shows unusual bacterial and fungal patterns, a new tool for measuring hidradenitis suppurativa severity was created, and gene expression changes in male baldness suggest new treatments.

New treatments and management strategies for skin conditions like melanoma and Spitz naevi were discussed at the dermatologists' meeting.

Runx1 affects hair growth, cancer development, and autoimmune diseases in epithelial tissues.

The Hedgehog signaling pathway is important for skin and hair growth and can lead to cancer if it doesn't work right.

Changing the environment around stem cells could help tissue repair, but it's hard to be precise and avoid side effects.

ΔNp63α helps control a protein that stops cancer cells from spreading.

Blocking enzymes that help the virus enter cells could be a promising way to treat COVID-19.